Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 12Mycosis Fungoides 11Sezary Syndrome 7Lymphoma 7Lymphoma, Primary Cutaneous Anaplastic Large Cell 2Recurrence 1Parapsoriasis 1Multiple Myeloma 1Lymphomatoid Papulosis 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Disease 1

Interventions

obinutuzumab 2venetoclax 1ofatumumab 1neratinib 1idelalisib 1ibrutinib 1Vindesine 1Vincristine 1Triamcinolone Acetonide 1Transcatheter Aortic Valve Replacement 1Th1-Th2 Balance 1Surveys and Questionnaires 1Rituximab 1Prednisone 1Positron Emission Tomography Computed Tomography 1Nivolumab 1Mechlorethamine 1Interviews as Topic 1HIV Testing 1Doxorubicin 1Diffusion Magnetic Resonance Imaging 1Cyclophosphamide 1Bleomycin 1Bexarotene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × Bexarotene × Lymphoid × Clear all
NCT05106192 2025-06-12

Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System.

Case Comprehensive Cancer Center

Phase NA Withdrawn
DermatologicLymphoid

Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphomatoid Papulosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡